Shell Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Shell Asset Management’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$13K	Buy	886 +43	+5%	+$515	﹤0.01%	1088
2025 Q2	$9K	Hold	843	–	–	﹤0.01%	1253
2025 Q1	$5K	Sell	843 -316	-27%	-$3.22K	﹤0.01%	1253
2024 Q4	$11K	Hold	1,159	–	–	﹤0.01%	1251
2024 Q3	$9K	Buy	+1,159	New	+$11.6K	﹤0.01%	1247
2024 Q1	$9K	Sell	679 -46	-6%	-$2.38K	﹤0.01%	1242
2023 Q4	$49K	Sell	725 -217	-23%	-$13.3K	﹤0.01%	1173
2023 Q3	$68K	Sell	942 -15	-2%	-$1.2K	﹤0.01%	1151
2023 Q2	$71K	Sell	957 -6	-0.6%	-$355	﹤0.01%	1175
2023 Q1	$51K	Sell	963 -3	-0.3%	-$190	﹤0.01%	1184
2022 Q4	$65K	Sell	966 -181	-16%	-$16.6K	﹤0.01%	1234
2022 Q3	$143K	Sell	1,147 -303	-21%	-$36.1K	0.01%	1125
2022 Q2	$138K	Buy	+1,450	New	+$177K	﹤0.01%	1210

Other funds holding DNA

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

ACG

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Shell Asset Management's DNA Position: Q3 2025 in Review

Shell Asset Management increased its Ginkgo Bioworks (DNA) stake by 5.1% in Q3 2025, buying an estimated $515 and bringing the position to 886 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #1088.

Shell Asset Management first reported a position in DNA in Q2 2022 and has held it in 13 quarters since. The position peaked at $143K in Q3 2022. 173 funds tracked by Wall St. Rank hold DNA as of Q3 2025.

Shell Asset Management held 886 shares of Ginkgo Bioworks worth $13K as of Q3 2025.
Shell Asset Management bought 43 Ginkgo Bioworks shares in Q3 2025, an estimated $515.
Ginkgo Bioworks made up ﹤0.01% of Shell Asset Management's portfolio in Q3 2025, its #1088 holding.
Shell Asset Management first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 13 quarters since.
Shell Asset Management's Ginkgo Bioworks position peaked at $143K in Q3 2022.
173 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.